OneOme Overview
- Founded
-
2013

- Status
-
Private
- Employees
-
45

- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$100K
- Investors
-
3
OneOme General Information
Description
Developer of pharmacogenomic and analytical solutions intended to help doctors select medications to improve outcomes and reduce adverse drug reactions. The company offers individual patient pharmacogenomic analysis and population management solutions to improve patient outcomes and reduce the total cost of care and combines leading-edge laboratory testing, advanced analytics, and clinical decision support solutions thereby serving health systems, payers, and employers.
Contact Information
Website
www.oneome.com
Formerly Known As
PGx Newco
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Decision/Risk Analysis
Diagnostic Equipment
Primary Office
- 807 Broadway Street North East
- Suite 100
- Minneapolis, MN 55413
- United States
+1 (844) 000-0000
OneOme Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Early Stage VC | 14-Jun-2017 | $100K | 00.000 | Completed | Generating Revenue | |
2. Seed Round | 05-Oct-2016 | 00.000 | 00.000 | Completed | Generating Revenue | |
1. Spin-Off | 01-Jan-2013 | Completed | Generating Revenue |
OneOme Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of pharmacogenomic and analytical solutions intended to help doctors select medications to improve outcomes an
Biotechnology
Minneapolis, MN
45
As of 2023
00.000
0000000000 0
00.000
OneOme Competitors (9)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Genomind | Venture Capital-Backed | King of Prussia, PA | 00 | 000.00 | 00000000000 | 000.00 |
0000 | Venture Capital-Backed | Seattle, WA | 00 | 000.00 | 0000000000 0 | 000.00 |
00000000 000000 | Formerly VC-backed | Mason, OH | 000 | 00000 | 000000&0 | 00000 |
000000 00000000 | Corporation | Salt Lake City, UT | 0000 | 00000 | 000000 - 000 | 00000 |
00000000 | Formerly PE-Backed | Miami, FL | 000 | 000000&0 |
OneOme Patents
OneOme Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20180135122-A1 | Systems and methods for genotype-derived drug recommendations | Inactive | 11-Nov-2016 | 0000000000 |
OneOme Executive Team (12)
OneOme Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Jeremy Friese | Self | Board Member | 000 0000 |
Patrick McIntyre | OneOme | Chief Executive Officer & Board Member | 000 0000 |
OneOme Signals
OneOme Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
LabCorp Ventures | Corporate Venture Capital | 000 0000 | 000000 0 | ||
Invenshure | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
Mayo Clinic Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |